Five decades on, Spain court convicts thalidomide maker

November 20, 2013

A court ordered the German maker of the banned pregnancy drug thalidomide to compensate Spanish victims who suffered birth defects from it in the 1960s, in a ruling released Wednesday.

The Spanish victims' group that brought the suit said it would be the first time ever that the German firm Grunenthal had been ruled responsible for the scandal, although it has already compensated some victims.

The case was the first suit brought in Spain against the manufacturer of the which the plaintiffs said caused in up to 3,000 Spanish babies.

Avite, an association representing Spaniards born with severe defects after their mothers took the drug during their pregnancies, had sought compensation of 204 million euros ($275 million) for its members.

In a written ruling dated Tuesday, the court said it convicted Grunenthal and sentenced it "to compensate each one of the plaintiffs" to tens of thousands euros each, depending on the severity of their disability, and to pay legal costs.

It did not specify exactly how many plaintiffs there were nor how much the compensation and costs would add up to in total. Avite claims to have 180 members.

Dozens of Spaniards born with defects caused by thalidomide, many in wheelchairs or on crutches, attended the trial in Madrid last month.

Thalidomide was originally marketed as a sedative, but from the late 1950s was prescribed to women around the world to combat morning sickness.

Many of the children of the mothers who took the drug were born with abnormally short limbs and in some cases without any arms, legs or hips.

In late 1961 the drug was withdrawn from the British and German markets, but it continued to be sold in other countries including Canada and Japan for months more.

Avite said it remained available in Spain until 1965.

The drug is estimated to have caused deformities in 10,000-20,000 babies in some 40 countries.

Grunenthal did not publicly apologise for the scandal until 2012.

Avite said in a statement ahead of the trial that it hoped the "historic lawsuit (would) appease the suffering of Spanish victims, which began in their mothers' wombs and continues today, with the amputation of their arms and legs".

Explore further: Spain court hears case against German maker of Thalidomide (Update)

Related Stories

Spain court hears case against German maker of Thalidomide (Update)

October 14, 2013
A Madrid court on Monday heard Spain's first lawsuit against German firm Grunenthal, the manufacturer of the morning sickness drug thalidomide which caused birth defects in thousands of babies.

Victims: Thalidomide sold in Spain post-withdrawal

May 8, 2013
(AP)—Spanish victims of thalidomide on Wednesday published documents they claim prove a German drug company kept distributing the notorious drug in Spain six months after it was taken off the market in other countries.

Australian wins millions in Thalidomide lawsuit

July 18, 2012
(AP) — An Australian woman born without arms and legs after her pregnant mother took the anti-morning sickness drug Thalidomide has reached a multimillion dollar settlement with the medicine's British distributor, her ...

Thalidomide maker 'ignored birth defects for years'

July 27, 2012
The German makers of thalidomide were warned of birth defects years before it was withdrawn and Australian distributors used pregnant women as the world's first test subjects, court papers alleged Friday.

Australian woman wins thalidomide hearing: court

December 19, 2011
A woman born without arms or legs on Monday won the right to have the class action she is leading against the firms behind thalidomide, a sedative blamed for birth defects, proceed in Australia.

Recommended for you

Mouse model aids study of immunomodulation

November 19, 2018
Because mice do not respond to immunomodulatory drugs (IMiDs), preclinical therapeutic and safety studies of the effects of IMiDs have not been possible in existing types of mice. This has led to an inability to accurately ...

Rapid response inpatient education boosts use of needed blood-thinning drugs

November 16, 2018
A new study designed to reach hospitalized patients at risk shows that a "real-time" educational conversation, video or leaflet can lower the missed dose rates of drugs that can prevent potentially lethal blood clots in their ...

Drug overdose epidemic goes far beyond opioids, requires new policies

November 7, 2018
Most government-funded initiatives to address the overdose epidemic in the United States have targeted opioids specifically and have neglected other drugs that are increasingly implicated in overdoses, such as cocaine and ...

Zebrafish larvae help in search for appetite suppressants

November 2, 2018
Researchers at the University of Zurich and Harvard University have developed a new strategy in the search for psychoactive drugs. By analyzing the behavior of larval zebrafish, they can filter out substances with unwanted ...

FDA OKs powerful opioid pill as alternative to IV painkiller

November 2, 2018
U.S. regulators on Friday approved a fast-acting, super-potent opioid tablet as an alternative to IV painkillers used in hospitals.

Amphetamine-related hospitalizations surged between 2003 and 2015

November 2, 2018
An analysis conducted by Hennepin Healthcare, University of Minnesota School of Public Health and University of Michigan researchers shows amphetamine-related hospitalizations increased more than 270 percent from 2008 to ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.